Pharmacological chaperones correct misfolded GPCRs and rescue function: protein trafficking as a therapeutic target
- PMID: 23161143
- DOI: 10.1007/978-94-007-4765-4_14
Pharmacological chaperones correct misfolded GPCRs and rescue function: protein trafficking as a therapeutic target
Abstract
G-protein-coupled receptors (GPCRs) are a large superfamily of plasma membrane proteins that play central roles in transducing endocrine, neural and -sensory signals. In humans, more than 30 disorders are associated with mutations in GPCRs and these proteins are common drug development targets, with 30-50% of drugs targeting them. GPCR mutants are frequently misfolded, recognized as defective by the cellular quality control system, retained in the endoplasmic reticulum and do not traffic to the plasma membrane. The use of small molecules chaperones (pharmacological chaperones or "pharmacoperones") to rescue misfolded GPCRs has provided a new approach for treatment of human diseases caused by misfolding and misrouting. This chapter provides an overview of the molecular basis of this approach using the human gonadotropin-releasing hormone receptor (hGnRHR) as model for treatment of conformational diseases provoked by -misfolded GPCRs.
Similar articles
-
Pharmacoperones: a new therapeutic approach for diseases caused by misfolded G protein-coupled receptors.Recent Pat Endocr Metab Immune Drug Discov. 2011 Jan;5(1):13-24. doi: 10.2174/187221411794351851. Recent Pat Endocr Metab Immune Drug Discov. 2011. PMID: 22074574 Free PMC article. Review.
-
Pharmacological chaperones for misfolded gonadotropin-releasing hormone receptors.Adv Pharmacol. 2011;62:109-41. doi: 10.1016/B978-0-12-385952-5.00008-7. Adv Pharmacol. 2011. PMID: 21907908 Free PMC article. Review.
-
G protein-coupled receptor trafficking in health and disease: lessons learned to prepare for therapeutic mutant rescue in vivo.Pharmacol Rev. 2007 Sep;59(3):225-50. doi: 10.1124/pr.59.3.2. Pharmacol Rev. 2007. PMID: 17878512 Review.
-
Use of pharmacoperones to reveal GPCR structural changes associated with constitutive activation and trafficking.Methods Enzymol. 2010;485:277-92. doi: 10.1016/B978-0-12-381296-4.00016-6. Methods Enzymol. 2010. PMID: 21050923
-
Therapeutic rescue of misfolded/mistrafficked mutants: automation-friendly high-throughput assays for identification of pharmacoperone drugs of GPCRs.Methods Enzymol. 2013;521:3-16. doi: 10.1016/B978-0-12-391862-8.00001-6. Methods Enzymol. 2013. PMID: 23351731
Cited by
-
Misfolded G Protein-Coupled Receptors and Endocrine Disease. Molecular Mechanisms and Therapeutic Prospects.Int J Mol Sci. 2021 Nov 15;22(22):12329. doi: 10.3390/ijms222212329. Int J Mol Sci. 2021. PMID: 34830210 Free PMC article. Review.
-
Emerging novel concept of chaperone therapies for protein misfolding diseases.Proc Jpn Acad Ser B Phys Biol Sci. 2014;90(5):145-62. doi: 10.2183/pjab.90.145. Proc Jpn Acad Ser B Phys Biol Sci. 2014. PMID: 24814990 Free PMC article. Review.
-
Using pharmacological chaperones to restore proteostasis.Pharmacol Res. 2014 May;83:3-9. doi: 10.1016/j.phrs.2014.04.002. Epub 2014 Apr 18. Pharmacol Res. 2014. PMID: 24747662 Free PMC article. Review.
-
TRP and Rhodopsin Transport Depends on Dual XPORT ER Chaperones Encoded by an Operon.Cell Rep. 2015 Oct 20;13(3):573-584. doi: 10.1016/j.celrep.2015.09.018. Epub 2015 Oct 8. Cell Rep. 2015. PMID: 26456832 Free PMC article.
-
How genetic errors in GPCRs affect their function: Possible therapeutic strategies.Genes Dis. 2015 Jun;2(2):108-132. doi: 10.1016/j.gendis.2015.02.005. Genes Dis. 2015. PMID: 26229975 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical